Patent directory · USPTO A61K / A61P
Patents matching “Theravance, Inc.”
369 pharma patents match "Theravance, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 369 pharmaceutical patents matching "Theravance, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7265086
Glycopeptide carboxy-saccharide derivatives
granted -
US 7262205
Biphenyl compounds useful as muscarinic receptor antagonists
granted -
US 7256294
Crystalline form of a benzimidazole-carboxamide medicinal compound
granted -
US 7250414
Diphenylmethyl compounds useful as muscarinic receptor antagonists
granted -
US 7244705
Polyacid glycopeptide derivatives
granted -
US 7238709
Therapeutic carbamates
granted -
US 7226946
Substituted phenol compounds useful for anesthesia and sedation
granted -
US 7226950
Sodium channel modulators
granted -
US 7223783
Indolinone derivatives
granted -
US 7217738
β2-adrenergic receptor agonists
granted -
US 7208471
Glycopeptide phosphonate derivatives
granted -
US 7208515
Diphenylmethyl compounds useful as muscarinic receptor antagonists
granted -
US 7195876
Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same
granted -
US 7183292
Substituted pyrrolidine and related compounds
granted -
US 7183323
Sodium channel modulators
granted -
US 7179794
Multivalent macrolide antibiotics
granted -
US 7173039
Protein kinase inhibitors
granted -
US 7160984
Process for preparing glycopeptide derivatives
granted -
US 7157554
Glycopeptide carboxy-saccharide derivatives
granted -
US 7151115
Diphenylmethyl compounds useful as muscarinic receptor antagonists
granted -
US 7141671
Biphenyl derivatives
granted -
US 7132422
Sodium channel modulators
granted -
US 7125892
Aryl aniline β2 adrenergic receptor agonists
granted -
US 7101964
Intermediate for preparing glycopeptide derivatives
granted